Bio-Rad Laboratories
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $693,200 | $653,000 | $651,600 | $585,400 |
Gross Profit | 345,200 | 343,400 | 345,300 | 306,000 |
EBITDA | 114,300 | 120,600 | 477,200 | 133,500 |
EBIT | 61,900 | 66,400 | 426,600 | 95,400 |
Net Income | 720,000 | -341,900 | 317,800 | 64,000 |
Net Change In Cash | 693,200 | 653,000 | 651,600 | 585,400 |
Free Cash Flow | 119,100 | 89,200 | 70,800 | 95,500 |
Cash | 531,799 | 397,800 | 369,300 | 521,400 |
Basic Shares | 27,012 | 26,923 | 27,228 | 27,955 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,583,200 | $2,566,500 | $2,671,262 | $2,802,249 |
Gross Profit | 1,343,600 | 1,378,900 | 1,426,946 | 1,567,330 |
EBITDA | 475,900 | -2,142,000 | -654,800 | -4,488,959 |
EBIT | 270,500 | -2,293,600 | -800,700 | -4,666,159 |
Net Income | 759,900 | -1,844,200 | -637,324 | -3,627,535 |
Net Change In Cash | 2,583,200 | 2,566,500 | 2,671,262 | 2,802,249 |
Cost of Revenue | -39,570 | |||
Free Cash Flow | 374,600 | 266,200 | 218,263 | 80,290 |
Cash | 531,799 | 488,100 | 403,800 | 434,215 |
Basic Shares | 27,281 | 28,214 | 29,209 | 29,785 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $2.51 |
2025-09-30 | $2.26 |
2025-06-30 | $2.61 |